pubs.acs.org/joc
3,4-dihydro-2H-1,4-benzoxazine, 1,4-benzodiazepin-3-one,
Copper-Catalyzed Cascade Syntheses of
2H-benzo[b][1,4]thiazin-3(4H)-ones and Quinoxalin-
2(1H)-ones through Capturing S and N Atom
Respectively from AcSH and TsNH2
etc.2 However, little report was found about the construction
of S-heterocycles via a one-pot copper-catalyzed S-arylation
process except for benzothiazole.3 The reason may be that
the thiols are prone to be oxidized dimerization or complexed
with metals, causing reduced catalytic efficiency. Therefore,
searching for a new sulfur reagent to apply it to the cascade
construction of S-heterocycles would be a research topic
worthy of study.
2H-Benzo[b][1,4]thiazin-3(4H)-one and quinoxalin-2(1H)-
one are important heterocycle scaffolds that display a wide
range of bioorganic and medicinal activities. For example,
2H-benzo[b][1,4]-thiazin-3(4H)-one derivatives act as anti-
microbial, anticancerous, immunostimulating, angiotensin
converting enzyme, aldose reductase inhibitors, and anti-
diabetic, antiarrhythmic inhibitors (Figure 1).4 Quinoxalin-
2(1H)-ones show antithrombotic, antitumor activity (Figure 1)
and are used as antimicrobial agents, kinases inhibitors,
benzodiazepine receptor agonist, etc.5
Dingben Chen,†,‡ Zhi-Jing Wang,† and Weiliang Bao*,†
†Department of Chemistry, Zhejiang University, Xi Xi
Campus, Hangzhou 310028, Zhejiang, People’s Republic of
China, and ‡College of Pharmaceutical and Chemical
Engineering, Taizhou University, Linhai 317000, Zhejiang,
People’s Republic of China
Received June 26, 2010
Some methods have been developed for the syntheses of
2H-benzo[b][1,4]thiazin-3(4H)-ones6 and quinoxalin-2(1H)-
ones.7 The classical synthesizing approaches of 2H-benzo[b]
[1,4]thiazin-3(4H)-ones are based on using 2-aminobenze-
nethiols or halonitrobenzenes as starting materials, which
are cyclized directly by reacting with acetyl halide, or sub-
stituted by thiol acetates and reduced to form a ring system.
Recently, Zuo and co-workers used 2-chlorobenzenthiols to
synthesize 2H-benzo[b][1,4]thiazin-3(4H)-ones via Smiles
A copper-catalyzed cascade method has been developed
to synthesize the 2H-benzo[b][1,4]thiazin-3(4H)-ones
from 2-halo-N-(2-halophenyl)-acetamides 1 and AcSH
via the SN2/deacetylation/coupling process, and to synthe-
size the quinoxalin-2(1H)-ones from 1 and TsNH2 via the
SN2/coupling/desulfonation process. The target products
were obtained with diversity at three positions on their
scaffolds.
(3) The examples for the synthesis of S-heterocycles via copper-catalyzed
one-pot strategies: (a) Ma, D.; Xie, S.; Xue, P.; Zhang, X.; Dong, J.; Jiang, Y.
Angew. Chem., Int. Ed. 2009, 48, 4222. (b) Muyyu, S.; Ghosh, H.; Sahoo,
S. K.; Patel, B. K. Org. Lett. 2009, 11, 4254. (c) Shen, G.; Lv, X.; Bao, W. Eur.
J. Org. Chem. 2009, 5897.
(4) (a) Grandolini, V.; Ambrogi, V.; Rossi, C.; Tiralti, L. Eur. J. Med.
Chem. 1986, 21, 455. (b) Gupta, R. R.; Dev, P. K.; Sharma, M. L.; Rajoria,
C. M.; Gupta, A.; Nyati, M. Anticancer Drugs 1993, 4, 589. (c) Todorov,
D. K.; Ilarionova, M. V.; Gupta, R. R.; Molna, J.; Motohashi, N. Hetero-
cycl. Commun. 1995, 1, 153. (d) Corona, L. D.; Signorelli, G.; Pinzetta, A.;
Coppi, G. Eur. J. Med. Chem. 1992, 27, 419. (e) Tawada, H.; Sugiyama, Y.;
Ikeda, H.; Yamamoto, Y.; Meguro, K. Chem. Pharm. Bull. 1990, 38, 1238.
(f) Matsui, T.; Nakamura, Y.; Ishikawa, H.; Matsuura, A.; Kobayashi, F.
Jpn. J. Pharmacol. 1994, 64, 115. (g) Fujita, M.; Ito, S.; Ota, A.; Kato, N.;
Yamamoto, K.; Kawashima, Y.; Yamauchi, H.; Iwao, J. J. Med. Chem.
1990, 33, 1898.
(5) (a) Ries, U. J.; Priepke, H. W. M.; Hauel, N. H.; Haaksma, E. E. J.;
Stassen, J. M.; Wienen, W.; Nar, H. Bioorg. Med. Chem. Lett. 2003, 13, 2297.
(b) Lawrence, D. S.; Copper, J. E.; Smith, C. D. J. Med. Chem. 2001, 44, 594.
(c) Carta, A.; Sanna, P.; Gherardini, L.; Usai, D.; Zanetti, S. Farmaco 2001,
56, 933. (d) Tung, C. L.; Sun, C. M. Tetrahedron Lett. 2004, 45, 1159.
(e) Jacobsen, E. J.; Stelzer, L. S.; TenBrink, R. E.; Belonga, K. L.; Carter,
D. B.; Im, H. K.; Im, W. B.; Sethy, V. H.; Tang, A. H.; VonVoigtlander, P. F.;
Petke, J. D.; Zhong, W. Z.; Mickelson, J. W. J. Med. Chem. 1999, 42, 1123.
(6) (a) Chhikara, B. S.; Mishra, A. K.; Tandon, V. Heterocycles 2004, 63,
1057. (b) Jacques, B. G.B. Patent 1115888, 1968. (c) Heravi, M. M.; Nami,
N.; Oskooie, H. A.; Hekmatshoar, R. Phosphorus, Sulfur Silicon Relat. Elem.
2005, 180, 1873. (d) Yamamoto, T.; Watanabe, I. W.O. Patent 9813357,
1998. (e) Wang, Z.; Yuan, Y.; Chen, Y.; Sun, G.; Wu, X.; Zhang, S.; Han, C.;
Wang, G.; Li, L.; Liu, G. J. Comb. Chem. 2007, 9, 652. (f) Dartois, C. G. Y.;
Markwell, R. E.; Madler, G. M. M. G.; Pearson, N. D. W.O. Patent 096907,
2002. (g) Miller, W. H.; Pearson, N. D.; Pendrak, I.; Seefeld, M. A. W.O.
Patent 064421, 2003. (h) Zuo, H.; Li, Z.; Ren, F. K.; Falck, J. R.; Ahn, C.;
Shin, D. S.; Lijuan, M. Tetrahedron 2008, 64, 9669.
In the past few years, copper-mediated formation of aryl
C-N and C-S bonds via Ullmann-type coupling reaction
has drawn considerable attention for their efficiency and low
cost.1 Recently, the copper-catalyzed coupling has been
successfully applied to the assembly of various heterocyclic
compounds by one-pot strategies. Many Cu(I)-catalyzed
cascade methods involving N-arylation have been reported
for the synthesis of N-heterocycles, including pyrrole, indole,
benzimidazole, 1,3-dihydrobenzimidazol-2-one, isoquino-
line, isoquinolin-1(2H)-one, quininazoline, quinazolinone,
(1) For recent reviews, see: (a) Evano, G.; Blanchard, N.; Toumi, M.
Chem. Rev. 2008, 108, 3054. (b) Ma, D.; Cai, Q. Acc. Chem. Res. 2008, 41,
1450. (c) Monnier, F.; Taillefer, M. Angew. Chem., Int. Ed. 2008, 47, 3096.
(d) Monnier, F.; Taillefer, M. Angew. Chem., Int. Ed. 2009, 48, 2.
(2) Selected examples for the synthesis of N-heterocycles via copper-
catalyzed one-pot strategies involving N-arylation: (a) Yuan, X.; Xu, X.;
Zhou, X.; Yuan, J.; Mai, L.; Li, Y. J. Org. Chem. 2007, 72, 1510. (b) Chen, Y.;
Wang, Y.; Sun, Z.; Ma, D. Org. Lett. 2008, 10, 625. (c) Yang, D.; Fu, H.; Hu,
L.; Jiang, Y.; Zhao, Y. J. Org. Chem. 2008, 73, 7841. (d) Li, Z.; Sun, H.; Jiang,
H.; Liu, H. Org. Lett. 2008, 10, 3263. (e) Wang, B.; Lu, B.; Jiang, Y.; Zhang,
Y.; Ma, D. Org. Lett. 2008, 10, 2761. (f) Wang, F.; Liu, H.; Fu, H.; Jiang, Y.;
Zhao, Y. Org. Lett. 2009, 11, 2469. (g) Huang, C.; Fu, Y.; Fu, H.; Jiang, Y.;
Zhao, Y. Chem. Commun. 2008, 6333. (h) Liu, X.; Fu, H.; Jiang, Y.; Zhao, Y.
Angew. Chem., Int. Ed. 2009, 48, 348. (i) Rao, R. K.; Naidu, A. B.; Sekar, G.
Org. Lett. 2009, 11, 1923. (j) Wang, H.; Jiang, Y.; Gao, K.; Ma, D.
Tetrahedron 2009, 65, 8956.
(7) (a) Rie, U. J.; Priepke, H. W. M.; Hauel, N. H.; Handschuh, S.; Mihm,
G.; Stassen, J. M.; Wienen, W.; Nar, H. Bioorg. Med. Chem. Lett. 2003, 13,
ꢀ
2297. (b) Bekerman, D. G.; Abasolo, M. I.; Fernandez, B. M. J. Heterocycl.
Chem. 1992, 29, 129. (c) Eller, G. A.; Datterl, B.; Holzer, W. J. Heterocycl.
Chem. 2007, 44, 1139.
5768 J. Org. Chem. 2010, 75, 5768–5771
Published on Web 07/28/2010
DOI: 10.1021/jo101253a
r
2010 American Chemical Society